Skip to main content
Log in

Renal protective effect of N-acetylcysteine with stepwise ramping voltage against extracorporeal shock wave lithotripsy-induced renal injury: a prospective randomized trial

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the role of combination of N-acetylcysteine with stepwise ramping voltage in renal protection against the ischemic, vascular and oxidative effects of extracorporeal shock wave lithotripsy.

Patients and methods

A prospective randomized trial on 164 adult patients scheduled for ESWL for single renal stones. Patients with radio-lucent stones, diabetes, hypertension, febrile UTI, and preoperative albuminuria were excluded from the study. Patients were randomized into one of four groups. Group A patients received maximal fixed voltage of ESWL. Group B patients received stepwise ramping voltage of ESWL. Group C patients received fixed maximal voltage with N-acetylcysteine (NAC) 600 mg/bid from 48 h before to 24 h after the procedure. Group D patients received gradual ramping voltage with NAC. Urinary β2-microglobulin, 24 h albumin and N-acetyl-β-d-glucosaminidase/creatinine ratio at 1 day and 5 days post-ESWL and the stone free rate at 2 weeks were measured.

Results

Group D was the only group that showed no significant difference pre and post ESWL in urinary albumin, β2-microglobulin and N-acetyl-β-d-glucosaminidase/creatinine ratio. Post hoc analysis revealed no significant difference between group B and group C in albumin, β2-microglobulin N-acetyl-β-d-glucosaminidase/creatinine ratio, but both of them had significantly lower levels than group A and significantly higher levels than group D. There was no statistically significant difference between all groups in the stone free rate at 2 weeks.

Conclusion

N-acetylcysteine protects the kidney against ESWL-induced renal injuries especially if combined with stepwise ramping voltage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Khan A (2018) Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int Urol Nephrol 50(5):799–806

    Article  CAS  Google Scholar 

  2. Drach GW, Dretler SW, Fair W, Finlayson B, Gillenwater J, Griffith D, Lingeman J, Newman D (1986) Report of the United States cooperative study of extracorporeal shock wave lithotripsy. J Urol 135:1127–1131

    Article  CAS  Google Scholar 

  3. Turk C, Knoll T, Petrik A, Skolarikos A, Neisius A, Seitz C, Thomas K (2020) Urolithiasis, EAU guidelines. http://uroweb.org/guideline/urolithiasis/. Accessed Dec 2020

  4. El-Nahas AR, Elsaadany MM, Diaa-Eldin T, Elshal AM, Abo El-Ghar M, Amani MI, Elsawy E, Hazem HS, Wafa E, Amira A, Barakat TS, Sheir KZ (2017) A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury. BJU Int 119:142–147

    Article  CAS  Google Scholar 

  5. Karlsen SJ, Smevik B, Stenstrom J, Berg KJ (1990) Acute physiological changes in canine kidneys following exposure to extracorporeal shock waves. J Urol 143:1280–1283

    Article  CAS  Google Scholar 

  6. Vicente MK, Djalma JF, Cesar OP, Oskar K, Anna TN, Valdemar O (2008) Effects of repeated extracorporeal shock wave on kidney apoptosis of normal and diabetic rat. Int Braz J Urol 34:91–96

    Article  Google Scholar 

  7. McAteer JA, Andrew PE (2008) The acute and long-term adverse effects of shock wave lithotripsy. Semin Nephrol 28(2):200–213

    Article  Google Scholar 

  8. Kerbl K, Rehman J, Landman J, Lee D, Sundaram C, Clayman RV (2002) Current management of urolithiasis: progress or regress? J Endourol 16:281–288

    Article  Google Scholar 

  9. Bolignano D, Donato V, Coppolino G, Campo S (2008) Neutrophil gelatinase associated lipocalin (NGAL) as a marker of kidney damage. Am J Kid Dis 52:595–605

    Article  CAS  Google Scholar 

  10. Delvecchio F, Auge BK, Munver R (2003) Shock wave lithotripsy causes ipsilateral renal injury remote from the focal point: the role of regional vasoconstriction. J Urol 169:1526–1529

    Article  CAS  Google Scholar 

  11. So Ra K, Yong-ho L, Sang-Guk L, Eun SK, Bong-Soo C, Jeong-Ho K, Byung-Wan L (2016) Urinary N-acetyl-b-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes. Med. 95(27):1–8

    Google Scholar 

  12. Honey RJ, Ray AA, Ghiculete D (2010) Shock wave lithotripsy: a randomized, double-blind trial to compare immediate versus delayed voltage escalation. J Urol 75:38–43

    Article  Google Scholar 

  13. Kim J, Jang HS, Park KM (2010) Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Renal Physiol 298(1):158–166

    Article  Google Scholar 

  14. Mazzon E, Britti D, De Sarro A, Caputi AP, Cuzzocrea S (2001) Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Pharmacol 424:75–83

    Article  CAS  Google Scholar 

  15. Birck R, Krzossok S, Markowetz F, Schnülle P, van der Woude FJ (2003) Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362:598–603

    Article  CAS  Google Scholar 

  16. El-Assmy A, Harraz A, Eldemerdash Y, Elkhamesy M, El-Nahas A, Elshal A, Sheir K (2016) Does lithotripsy increase stone recurrence? A comparative study between extracorporeal shockwave lithotripsy and non-fragmenting percutaneous nephrolithotomy. Arab J Urol 14(2):108–114

    Article  Google Scholar 

  17. Skuginna V, Nguyen DP, Seiler R, Kiss B, Thalmann GN, Roth B (2016) Does stepwise voltage ramping protect the kidney from injury during extracorporeal shockwave lithotripsy? Results of a prospective randomized trial. Eur Urol 69:267–273

    Article  Google Scholar 

  18. Kehinde EO, Al-Awadi KA, Al-Hunayan A (2008) Antioxidant therapy is associated with a reduction in the serum levels of mediators of renal injury following lithotripsy for renal calculi. J Endourol 22:2537–2545

    Article  Google Scholar 

  19. Li BL, Weizheng Z, Puyun L (1995) Protective effects of nifedipine and allopurinol on high energy shock wave induced acute changes of renal function. J Urol 153:596–598

    Article  CAS  Google Scholar 

  20. Strohmaier WL, Bichler KH, Koch J, Balk N, Wilbert DM (1993) Protective effect of verapamil on shock wave induced renal tubular dysfunction. J Urol 150:27–29

    Article  CAS  Google Scholar 

  21. Ogiste JS, Nejat RJ, Rashid HH, Greene T, Gupta M (2003) The role of mannitol in alleviating renal injury during extracorporeal shock waves lithotripsy. J Urol 169:875–877

    Article  Google Scholar 

  22. Connors BA, Evan AP, Blomgren PM, Handa RK, Willis LR, Gao S (2009) Effect of initial shock wave voltage on shock wave lithotripsy-induced lesion size during step-wise voltage ramping. BJU Int 103(1):104–107

    Article  Google Scholar 

  23. Demirci D, Mustafa S, Yalcin E, Ekmekcioglu O, Gulmez I, Karacagil M (2007) Comparison of conventional and step-wise shockwave lithotripsy in management of urinary calculi. J Endourol 21:1407–1410

    Article  Google Scholar 

  24. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343(3):180–184

    Article  CAS  Google Scholar 

  25. Nallamothu BK, Shojania KG, Saint S, Hofer TP, Humes HD, Moscucci M, Bates ER (2004) Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 117:938–947

    Article  CAS  Google Scholar 

  26. Renfan XU, Anyu T, Yang B, Youbin D, Guangzhi C (2016) Effectiveness of N-acetylcysteine for the prevention of contrast-induced nephropathy: asystematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 5(9):1–31

    Google Scholar 

  27. Wen-Qi M, Zhao Y, Wang Y, Xi-Qiong H, Zhu Y, Nai-Feng L (2018) Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials. Int Urol Nephrol 50(6):1085–1095

    Article  Google Scholar 

  28. Erturk M, Uslu N, Gorgulu S, Akbay E, Kurtulus G, Akturk IF, Akgul O, Surgit O, Uzun F, Gul M, Isiksacan N, Yildirim A (2014) Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin c? J Coron Artery Dis 25:111–117

    Article  Google Scholar 

  29. Ceylan B, Ozansoy M, Kilic U, Yozgat Y, Ercan C, Yildiz P, Aslan T (2018) N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions. Ren Fail 40(1):423–434

    Article  CAS  Google Scholar 

  30. Chi-Fai N, Chi Hang Y, Jeremy YC, Becky L, Steven CH, Christine YP, Wong KT, Winnie CW, John Y (2019) Effect of stepwise voltage escalation on treatment outcomes following extracorporeal shock wave lithotripsy of renal calculi: a prospective randomized study. J Urol 201(5):1121–1126

    Google Scholar 

  31. Al-Awadi KA, Kehinde EO, Loutfi I, Mojiminiyi OA, Al-Hunayan A, Abdul-Halim H, Al-Sarraf A, Memon A, Abraham MP (2008) Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants. Urol Res 36(1):51–60

    Article  CAS  Google Scholar 

  32. Christian G, Hans-Goran T (2018) How can and should we optimize extracorporeal shockwave lithotripsy? Urolithiasis 46:3–17

    Article  Google Scholar 

  33. Armaly Z, Artol S, Jabbour A, Saffouri A, Habashi N, Abd Elkadir A, Ghattas N, Farah R, Kinaneh S, Nseir W (2019) Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients. Ren Fail 41(1):976–986

    Article  CAS  Google Scholar 

  34. Mehmet NM, Yakup B, Ender Ö, Şaban S (2019) Protective effects of oral sirolimus therapy against ESWL-induced kidney tissue damage in rats. J Urol Surg 6(3):190–195

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maged M. Ali.

Ethics declarations

Conflict of interest

The authors declare that they have no relevant financial interests or conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 23 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Desoky, E.A.E., Sakr, A.M., Alhefnawy, M. et al. Renal protective effect of N-acetylcysteine with stepwise ramping voltage against extracorporeal shock wave lithotripsy-induced renal injury: a prospective randomized trial. Int Urol Nephrol 52, 2261–2267 (2020). https://doi.org/10.1007/s11255-020-02580-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-020-02580-1

Keywords

Navigation